We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GSRF:NASDAQGSR IV Acquisition Corp. Analysis

Data as of 2026-06-21 - not real-time

$10.15

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

GSR IV Acquisition Corp. (GSRF) trades at a steep $10.15 price with a trailing P/E of 72.5, far above the industry average of 16.9, indicating significant overvaluation. The technical picture shows a bullish trend as the 20‑day SMA (10.14) sits just above the 50‑day SMA (10.11) and the 200‑day SMA (10.05), but momentum is waning with an RSI of 72.9 (overbought) and a bearish MACD signal. Volume is sharply declining, with today’s 91 shares traded versus a three‑month average of over 14,000, raising liquidity concerns. The company holds negligible cash ($1.31 M) and no debt, yet it reports zero revenue, negative operating cash flow, and a negative book value per share (-$0.264), underscoring the speculative nature of SPAC structures. Market sentiment is extremely bullish (Fear & Greed Index 91.46, “Extreme Greed”), but the lack of operating fundamentals and the overextended valuation suggest caution.
Given the high overvaluation, minimal liquidity, and absence of earnings, short‑term investors should consider exiting positions, while medium‑ to long‑term participants may adopt a wait‑and‑see stance pending a credible business combination. The low beta (≈0) masks underlying SPAC risk, and the thin trading depth could exacerbate price swings if market sentiment shifts.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI in overbought territory
  • Bearish MACD signal
  • Sharp decline in trading volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential SPAC merger catalyst
  • Bullish SMA alignment
  • Extremely low beta reducing market‑wide volatility exposure

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Absence of operating revenue and negative book value
  • Uncertainty around future business combination
  • Continued overvaluation relative to earnings

Key Metrics & Analysis

Financial Health

P/E Ratio72.5
P/B Ratio-38.4
Op. Cash Flow$-975596
Industry P/E16.9

Technical Analysis

TrendBullish
RSI72.9
Support$10.13
Resistance$10.16
MA 20$10.14
MA 50$10.11
MA 200$10.05
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

GradeOvervalued
TypeBlend

Risk Assessment

Beta0.01
Volatility1.39%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.